Anti-secretory and anti-proliferative actions of next-generation dual subtype 2 and 5 somatostatin receptor ligands in neuroendocrine tumor models.
Saved in:
| Title: | Anti-secretory and anti-proliferative actions of next-generation dual subtype 2 and 5 somatostatin receptor ligands in neuroendocrine tumor models. |
|---|---|
| Authors: | Fedeli F; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Bistika M; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Ascione F; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Marangelo A; Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.; Joint Heidelberg-Institute for Diabetes and Cancer (IDC) Translational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany., Guzzi FL; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Schrader J; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Harris AG; Holman Division of Diabetes Endocrinology & Metabolism, New York University (NYU) Langone Medical Center, Grossman School of Medicine, New York University, New York, NY, United States., Pellegata NS; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Feb 27; Vol. 16, pp. 1766563. Date of Electronic Publication: 2026 Feb 27 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2026.1766563 |
